Product
NHS-IL12
2 clinical trials
9 indications
Indication
Cervical CancerIndication
Human Papillomavirus CancersIndication
Anal CancerIndication
Oropharyngeal CancerIndication
VulvarIndication
VaginalIndication
PenileIndication
Rectal CancerIndication
Kaposi SarcomaClinical trial
Phase I/II Trial of Combination Immunotherapy in Subjects With Advanced HPV Associated MalignanciesStatus: Active (not recruiting), Estimated PCD: 2022-07-26
Clinical trial
Phase I/II Study of NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaStatus: Recruiting, Estimated PCD: 2025-09-01